Savara Reports Third Quarter Financial Results and Provides Business Update
| SVRA Stock | USD 3.36 0.20 5.62% |
About 61% of Savara's investor base is looking to short. The analysis of the overall investor sentiment regarding Savara Inc suggests that many traders are alarmed. The current market sentiment, together with Savara's historical and current headlines, can help investors time the market. In addition, many technical investors use Savara Inc stock news signals to limit their universe of possible portfolio assets.
Savara |
Savara Inc. , a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results
Read at businesswire.com
 |
Savara Fundamental Analysis
We analyze Savara's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Savara using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Savara based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Savara is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Savara Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Savara stock to make a market-neutral strategy. Peer analysis of Savara could also be used in its relative valuation, which is a method of valuing Savara by comparing valuation metrics with similar companies.
Peers
Savara Related Equities
| PTIX | Protagenic Therapeutics | 5.77 | ||||
| ACLX | Arcellx | 5.73 | ||||
| IKNA | Ikena Oncology | 1.80 | ||||
| FENC | Fennec Pharmaceuticals | 1.32 | ||||
| EWTX | Edgewise Therapeutics | 1.15 | ||||
| CRNX | Crinetics Pharmaceuticals | 0.97 | ||||
| XOMAO | XOMA | 0.40 | ||||
| XOMA | XOMA Corp | 0.47 | ||||
| KZR | Kezar Life | 0.86 | ||||
| AVTE | Aerovate Therapeutics | 1.14 | ||||
| GPCR | Structure Therapeutics | 1.30 | ||||
| RZLT | Rezolute | 1.39 | ||||
| RVMD | Revolution Medicines | 1.82 | ||||
| STOK | Stoke Therapeutics | 2.11 | ||||
| XLO | Xilio Development | 2.80 | ||||
| TRDA | Entrada Therapeutics | 2.97 | ||||
| DYN | Dyne Therapeutics | 3.04 | ||||
| ALXO | Alx Oncology | 4.43 | ||||
| TPST | Tempest Therapeutics | 4.49 | ||||
| SRRK | Scholar Rock | 5.26 | ||||
| TARA | Protara Therapeutics | 6.30 | ||||
| ANAB | AnaptysBio | 32.83 |
Complementary Tools for Savara Stock analysis
When running Savara's price analysis, check to measure Savara's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Savara is operating at the current time. Most of Savara's value examination focuses on studying past and present price action to predict the probability of Savara's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Savara's price. Additionally, you may evaluate how the addition of Savara to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |